Advancement in CAR T-Cell Therapy in Tumors Current Challenges and Future Directions

Dr. Umesh Kumar
is currently serving as Associate Director in Chandigarh University, Mohali, Punjab. He has been a Professor and Head, Research Cell in the Department of Biosciences at IMS Ghaziabad (University Courses Campus), Ghaziabad, Uttar Pradesh. He also worked as a Scientific Officer in the Department of Biochemistry at the University of Delhi. His research interests encompass a range of topics, including the molecular diagnosis of cervical cancer, the molecular epigenetics of breast carcinogenesis, CAR T-cell therapy, mesenchymal stem cells, epithelial ovarian carcinoma, and tumor virology. 

Dr. Anil Kumar
is presently working as Staff Scientist in the National Institute of Immunology, New Delhi. His research interest focuses on understanding the link between gut microbiota and human cancer as well as how the result of the investigation may be helpful to devise strategies to develop gut bacteria/metabolite-based adjuvant immunotherapy for the treatment of colorectal cancer.His research group is also working on exploring the anticancer potential of gut microbiota derived metabolites for cancer treatment. He had participated in the development of biosensors which have been transferred to industry. In 2012, one of his patents has been selected for CSIR Technology Award 2012 and other US patent won Merck Millipore India Innovation Award 2012.

Dr. Deepak Parashar
is an Assistant Professor in the laboratory of Siegfried Janz in the Division of Hematology and Oncology, Department of Medicine, at the Medical College of Wisconsin (MCW), Milwaukee. His long-term research interests involve the development of a comprehensive understanding of key developmental pathways and how alterations in gene expression contribute to human cancer. His academic training and research experience have provided him with an excellent background in multiple biological disciplines including molecular biology, biochemistry, and genetics.